Clinical Trials Update: Feb. 8, 2007
Vaccines Bipolar Disorders Shingles
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate an investigational vaccine for meningococcal disease. Healthy people ages 11 to 55 may be eligible to participate. Compensation for time and travel will be provided to those who qualify.
The research site is in Pittsburgh, Penn.
This is a clinical research study of an investigational drug to treat bipolar disorder. Participants must be 18-65, diagnosed with bipolar disorder, or have symptoms such as: decreased need for sleep, distractibility, irritability, depression, insomnia, weight loss or gain, pressured speech, racing thoughts, difficulty concentrating, or feelings of hopelessness. Participants cannot be diabetic, and additional criteria may apply.
The research site is in Cincinnati, Ohio.
This study will evaluate an investigational vaccine for shingles. You may qualify if you are ages 50 to 59 and have had chicken pox. Qualified participants may be compensated up to $100 for time and travel.
The research site is in Murray, Utah.
Copyright 2007 Thomson CenterWatch. All rights reserved.